Major Bleeding Risk Associated With Antithrombotics
NCT02886533 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6484
Last updated 2023-11-18
Summary
Prospective, multicenter, observational study with a three-year inclusion period (from January 1, 2012 to December 31, 2015) and a 6-month follow-up
Conditions
- Major Haemorrhage
Interventions
- OTHER
-
Antithrombotic
Collection of clinical, biological data
Sponsors & Collaborators
-
Rennes University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-01
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- France
Study Locations
More Related Trials
-
Clinical Trial to Assess the Efficacy of Tranexamic Acid in Reducing Blood Loss in Hip Fracture Patients.
NCT05489185 ·Status: UNKNOWN ·Phase: PHASE4
-
Noninferiority Oral Tranexamic Acid vs Intravenous Administration in Total Hip Arthroplasty
NCT04691362 ·Status: COMPLETED ·Phase: PHASE4
-
Risk Factors of Epistaxis Recurrence in Adults
NCT06657053 ·Status: NOT_YET_RECRUITING
-
Management of Anticoagulants and Antithrombotics in Patients With CSDH
NCT05079295 ·Status: UNKNOWN
-
Impact of Tachycardia on Outcome After Subarachnoid Hemorrhage (SAH)
NCT01585311 ·Status: TERMINATED
-
Management of Bleeding and Coagulopathy in Trauma and Compliance to European Trauma Guidelines
NCT02884999 ·Status: COMPLETED
-
Primary and Secondary Hemostasis in Elective Coronary Artery Bypass Graft Surgery
NCT00825981 ·Status: COMPLETED
-
Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage
NCT06322953 ·Status: RECRUITING ·Phase: PHASE3
-
Management of Gastrointestinal Bleeding Under Direct Oral Anticoagulants
NCT07333144 ·Status: RECRUITING
-
Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma
NCT03582293 ·Status: RECRUITING ·Phase: PHASE3
-
Antibiotic-associated Coagulopathy
NCT02172833 ·Status: UNKNOWN
-
Tranexamic Acid Versus Placebo to Reduce Perioperative Bleeding After Major Hepatectomy
NCT00657384 ·Status: TERMINATED ·Phase: PHASE3
-
Auto-administered Questionnaire by Screening of Disorder of the Haemostasis in Preoperative
NCT02886117 ·Status: COMPLETED
-
Medication Exposure in Older Patients With Constitutional Hemorrhagic Disease
NCT04282486 ·Status: COMPLETED
-
Tranexamic Acid in the Treatment of Residual Chronic Subdural Hematoma
NCT03280212 ·Status: UNKNOWN ·Phase: PHASE3
-
Perioperative Management of Factor Xa Inhibitors
NCT05801068 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of TXA Prior to Surgery in the Geriatric Hip Fracture Population
NCT03923959 ·Status: COMPLETED ·Phase: PHASE3
-
Single Dose of Tranexamic Acid and Blood Loss, in Elderly Patients With Hip Fracture
NCT03251469 ·Status: UNKNOWN ·Phase: PHASE2
-
Occurrence of Bleeding and Thrombosis During Antiplatelet Therapy in Non-cardiac Surgery
NCT01358422 ·Status: COMPLETED
-
Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders
NCT07083583 ·Status: RECRUITING
-
Blood-sparing During Hip Prosthesis Surgery With Exacyl® in Patients Treated With Rivaroxaban
NCT02403596 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Pre-test Probability Model for Heparin-induced Thrombocytopenia in Post-operative Cardiac Surgery
NCT05783895 ·Status: UNKNOWN
-
A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients
NCT00198575 ·Status: UNKNOWN
-
Hemostasis Profile in Patients With Severe Subarachnoid Hemorrhage
NCT03745456 ·Status: UNKNOWN
-
Study Comparing Topical Versus Intravenous Tranexamic Acid in Anterior Total Hip Arthroplasty
NCT03359525 ·Status: UNKNOWN ·Phase: PHASE4